lobbying_activities: 1559841

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1559841	c8211df9-8087-4a23-80cf-3791bf42e47a	Q2	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2014	second_quarter	PHA	Issues relating to the Medicare Prescription Drug Act; budgetary issues pertaining to Medicare Part D; issues relating to a report on clinical trials and minority communities; 340B Drug Pricing Program; and possible amendments to agriculture appropriations legislation relating to pharmaceuticals.	HOUSE OF REPRESENTATIVES	40000		0	0	2014-07-18T12:04:07.887000-04:00